IPO Date: Jan 21 to Jan 23 2026
Listing Date: Jan 29 2026
1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities;
2. Purchase of CRM Software and Hardware Infrastructure;
3. Human Resources;
4. Repayment/Prepayment of loan;
5. To meet out the Working Capital requirements of the Company and
6. To meet out the General Corporate Purposes;
A-16, G T Karnal Road Industrial Area North West
Delhi
Delhi
110033
9289101700
compliance@krmayurveda.com
www.krmayurvedaindia.com
Skyline Financial Services Pvt Ltd
Pursuant to the Listing Regulations, HealthCare Global Enterprises has confirmed that there were no deviations or variations in the utilisation of the proceeds raised through the Rights Issue of the Company during the quarter ended March 31, 2026, from the objects stated in the Letter of Offer dated February 24, 2026. In this regard, it has enclosed, as Annexure, the statement confirming that there was no deviation or variation in the utilisation of the aforesaid proceeds for the quarter ended March 31, 2026, from the objects stated in the Letter of Offer, in accordance with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019. The said statement has been duly reviewed by the Audit Committee of the Company. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.
The above information is a part of company’s filings submitted to BSE.
Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Priya has informed that a meeting of the Board of Directors of the Company will be held on Thursday, the 28th day of May, 2026 at the registered office of the Company, to consider the following matters: i) To approve the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2026. ii) Any other matter with the permission of Chairman. Further, pursuant to the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of ‘Code of Conduct for Regulation, Monitoring and Reporting of Trading by Insiders’ of the Company, the trading window for dealing with securities of the Company is closed from Wednesday 1st April, 2026 and will end 48 hours after the results are made to public on Monday 1st June, 2026. The same has been informed to the Directors and Specified persons as defined in the code.
No Records Found
The issue size of KRM Ayurveda Ltd. IPO is ₹53.73 - 56.67 crore.
The KRM Ayurveda Ltd. IPO opens for subscription on 2026-01-21 and closes on 2026-01-23.
The price range of KRM Ayurveda Ltd. IPO is ₹128.00 to ₹135.00.
The lot size of KRM Ayurveda Ltd. IPO is 2000 shares.
The registrar of KRM Ayurveda Ltd. IPO is Skyline Financial Services Pvt Ltd .
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.